查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2141370

稀有糖市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Rare Sugar Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球稀有糖市場預計到 2025 年將達到 14 億美元，年複合成長率為 5.4%，到 2035 年將達到 24 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 14億美元
預計金額 24億美元
複合年成長率 5.4%

稀有糖市場包括D-甘露糖、阿洛酮糖（D-阿洛酮糖）、塔格糖和阿洛糖。這些單醣在自然界中含量極低，可透過酵素轉化、發酵或化學合成等方法進行商業性生產。隨著生產商和原料供應商不斷拓展其在食品、飲料、藥品和膳食補充劑等領域的應用，市場成長不再僅依賴單一的健康導向價值提案。 D-甘露糖仍然是最大的收入來源，這主要得益於其在醫藥級補充劑應用中的高定價。另一方面，阿洛酮糖的商業性機會正在不斷擴大，因為它有助於開發低熱量產品，而且其生產和供給能力也持續成長。塔格糖作為一種低升糖指數（GI）原料，在食品、藥品和營養保健品領域也展現出獨特的成長動能。消費者對更健康配方、低糖、潔淨標示成分和功能性營養的日益關注，正在推動其市場普及。因此，製造商們正致力於提高生產規模、產品純度、應用開發以及獲得監管部門的批准，以抓住全球市場的新機會。

預計到2025年，D-甘露糖市場規模將達到6.202億美元，並在2035年之前以1%的複合年成長率成長。其在尿道感染治療的應用持續支撐著商業性需求，而醫藥級D-甘露糖嚴格的純度要求也推高了其價格。目前，D-甘露糖的平均價格約為每噸1萬美元。 Ardilla Technologies公司在芬蘭拉普阿的自有工廠生產結晶質D-甘露糖，採用層析法分離結合結晶製程。該公司的產品線已獲得ISO 9001、猶太潔食認證和清真認證，這進一步增強了其對追求明確品質和認證標準的客戶的吸引力。

2025年，粉末和結晶質型D-甘露糖產品市場規模達9.086億美元。由於其能夠實現精準計量、提供優異的儲存穩定性並能高效地融入現有的乾燥製作流程，這種形態的D-甘露糖在補充劑、片劑、膠囊、乾粉混合物和高階食品配料領域佔據著穩固的地位。松谷化學工業株式會社和泰萊公司的結晶質產品，包括松谷化學工業株式會社的結晶質型阿洛酮糖“ASTRAEA”和泰萊公司的結晶質原料“DOLCIA PRIMA”，進一步證明了這種產品形態在高階應用中的商業性重要性。預計到2035年，粉末和結晶質型D-甘露糖產品市場將以4.4%的複合年成長率成長。儘管這些形態仍將佔據重要的商業性地位，但隨著液態稀有糖在相關應用中得到更廣泛的認可，其市場佔有率預計將會逐漸下降。

預計到2025年，北美稀有糖市場規模將達到4.617億美元，並在2035年之前以4.5%的複合年成長率成長。完善的美國GRAS（公認安全）認證流程、對阿洛酮糖標籤的監管以及本土製造地，共同支撐著該地區成熟的稀有糖產業。嘉吉公司位於愛荷華州的生產設施、泰萊公司位於伊利諾州的營運機構以及邦納莫伊斯公司位於維吉尼亞的工廠，進一步增強了本土供給能力。美國食品藥物管理局（FDA）和加拿大監管機構的法律規範也促進了市場發展，而進口原料則有助於滿足日益成長的潔淨標示食品和膳食補充劑需求。法律規範確保了該地區在全球稀有糖市場中保持領先。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
      • 全球對更健康、低熱量甜味劑取代傳統糖的需求日益成長。
      • 糖尿病和肥胖症的日益普及正在推動功能性糖的創新。
    • 產業潛在風險與挑戰
      • 生產成本高且缺乏大規模生產能力。
      • 關於新型稀有糖的監管不確定性，且全球各國核准情況不一。
    • 市場機遇
      • 全球消費市場中「潔淨標示」和「天然成分」的趨勢日益成長。
      • 酵素和微生物生產技術的進步使得經濟高效的糖合成成為可能。
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 價格趨勢
    • 按地區
    • 稀有糖的種類
  • 未來市場趨勢
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 專利趨勢
  • 貿易統計資料（註：貿易統計僅包含主要國家的資料）
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 具有環保意識的舉措
  • 考慮碳足跡

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • LATAM
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依稀有糖類型分類，2022-2035年

  • D-甘露糖
  • 阿洛酮糖
  • 塔加托斯
  • 箭頭

第6章 市場估算與預測：依產品類型分類，2022-2035年

  • 粉末/結晶質
  • 液體/糖漿
  • 其他產品類型

第7章 市場估計與預測：依應用領域分類，2022-2035年

  • 食品/飲料
  • 製藥
  • 化妝品
  • 營養保健品
  • 其他用途

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第9章：公司簡介

  • Anderson Global Group, LLC
  • Ardilla Technologies
  • Bonumose
  • Cargill
  • Daesang Corporation
  • Matsutani Chemical Industry Co., Ltd
  • Roquette Freres
  • Samyang Corporation
  • SAVANNA Ingredients GmbH
  • Shandong Bailong Chuangyuan Bio-tech Co., Ltd
  • Shandong Fuyang Bio-tech Co., Ltd
  • Tate & Lyle PLC
簡介目錄
Product Code: 4458

The Global Rare Sugar Market was valued at USD 1.4 billion in 2025 and is estimated to grow at a CAGR of 5.4% to reach USD 2.4 billion by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$1.4 Billion
Forecast Value$2.4 Billion
CAGR5.4%

The rare sugar market covers D-Mannose, allulose (D-psicose), tagatose, and allose, which are monosaccharides that occur naturally in very small quantities and are commercially manufactured through enzymatic conversion, fermentation, or chemical synthesis. Market growth is no longer driven by a single health-focused value proposition, as manufacturers and ingredient suppliers are expanding applications across food, beverages, pharmaceuticals, and nutraceuticals. D-Mannose continues to account for the largest revenue base, supported by premium pricing associated with pharmaceutical-grade supplement applications. At the same time, allulose is expanding its commercial opportunity by enabling lower-calorie formulations and benefiting from increasingly scalable production and supply capabilities. Tagatose is also creating a distinct growth avenue as a low-glycemic ingredient with applications spanning food, pharmaceutical, and nutraceutical products. Rising consumer interest in healthier formulations, sugar reduction, clean-label ingredients, and functional nutrition is supporting broader adoption. Manufacturers are therefore focusing on production scalability, product purity, application development, and regulatory acceptance to capture emerging opportunities across global markets.

D-Mannose segment held USD 620.2 million in 2025 and is forecast to grow at a CAGR of 1% through 2035. Its application in urinary tract infection management continues to support commercial demand, while stringent pharmaceutical-grade purity requirements contribute to premium pricing. Average pricing for D-Mannose remains near USD 10,000 per ton. Ardilla Technologies manufactures crystalline D-Mannose at its facility in Lapua, Finland, using chromatographic separation followed by crystallization. The company's product offering is supported by ISO 9001, Kosher, and Halal credentials, which strengthen its suitability for customers requiring defined quality and certification standards.

Powder and crystalline products segment captured USD 908.6 million in 2025. The format maintains a strong position in D-Mannose supplements, tablets, capsules, dry blends, and premium food ingredients because it supports accurate dosing, provides good shelf stability, and integrates efficiently with established dry-processing operations. Crystalline formats from Matsutani Chemical Industry and Tate & Lyle further demonstrate the commercial importance of this product form in high-specification applications, including Matsutani's ASTRAEA crystalline allulose and Tate & Lyle's DOLCIA PRIMA crystalline ingredient. The powder/crystalline segment is forecast to expand at a 4.4% CAGR through 2035. Although these formats will remain commercially significant, their market share is expected to gradually decline as liquid rare sugar formats gain greater acceptance across suitable applications.

North America Rare Sugar Market recorded USD 461.7 million in 2025 and is forecast to grow at a CAGR of 4.5% through 2035. Established U.S. GRAS pathways, the regulatory treatment of allulose labeling, and domestic manufacturing operations support the region's mature rare sugar industry. Cargill's production presence in Iowa, Tate & Lyle's operations in Illinois, and Bonumose's presence in Virginia further support domestic supply capabilities. Regulatory frameworks involving the U.S. Food and Drug Administration and Canadian authorities also contribute to market development, while imported ingredients help meet demand associated with growing adoption of clean-label food products and dietary supplements. The combination of established regulatory pathways, domestic production, and consumer demand for healthier ingredients continues to support the region's position in the global rare sugar market.

Major companies operating in the global rare sugar market include Daesang Corporation, Tate & Lyle PLC, Cargill, Roquette Freres, and Matsutani Chemical Industry Co. Ltd. Companies in the global rare sugar market are strengthening their market foothold through capacity expansion, product innovation, strategic collaborations, application development, and geographic expansion. Leading participants are investing in advanced production technologies to improve yields, scalability, purity, and cost efficiency while addressing growing demand across food, beverage, pharmaceutical, and nutraceutical applications. Companies are also expanding their product portfolios to cover different rare sugar formats and formulation requirements. Strategic partnerships with food manufacturers, ingredient distributors, research organizations, and technology providers help broaden commercial reach and accelerate product development. Regulatory approvals and certifications remain important for gaining access to new applications and markets. Manufacturers are also focusing on supply-chain reliability, customer-specific formulations, and stronger distribution networks. Investments in research and development, sustainable production methods, and new processing technologies further help companies differentiate their offerings and build stronger long-term positions in the rare sugar industry.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Rare sugar type
    • 2.2.3 Product type
    • 2.2.4 Application
  • 2.3 TAM Analysis, 2025-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising global demand for healthier low-calorie sweeteners replacing conventional sugars
      • 3.2.1.2 Increasing prevalence of diabetes and obesity driving functional sugar innovation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High production costs and limited large-scale manufacturing capabilities
      • 3.2.2.2 Regulatory uncertainties and varying global approvals for emerging rare sugars
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expanding clean-label and natural ingredient trends across global consumer markets
      • 3.2.3.2 Advances in enzymatic and microbial production improving cost-efficient sugar synthesis
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By rare sugar type
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Rare Sugar Type, 2022-2035 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 D-Mannose
  • 5.3 Allulose
  • 5.4 Tagatose
  • 5.5 Allose

Chapter 6. Market Estimates and Forecast, By Product Type, 2022-2035 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder/Crystalline
  • 6.3 Liquid/Syrup
  • 6.4 Other Product Types

Chapter 7. Market Estimates and Forecast, By Application, 2022-2035 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Food and beverage
  • 7.3 Pharmaceuticals
  • 7.4 Cosmetics
  • 7.5 Nutraceuticals
  • 7.6 Other applications

Chapter 8. Market Estimates and Forecast, By Region, 2022-2035 (USD Million) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9. Company Profiles

  • 9.1 Anderson Global Group, LLC
  • 9.2 Ardilla Technologies
  • 9.3 Bonumose
  • 9.4 Cargill
  • 9.5 Daesang Corporation
  • 9.6 Matsutani Chemical Industry Co., Ltd
  • 9.7 Roquette Freres
  • 9.8 Samyang Corporation
  • 9.9 SAVANNA Ingredients GmbH
  • 9.10 Shandong Bailong Chuangyuan Bio-tech Co., Ltd
  • 9.11 Shandong Fuyang Bio-tech Co., Ltd
  • 9.12 Tate & Lyle PLC